Blog

 

Redhill To Start Phase III Crohn’s

RedHill Biopharma Ltd. (NASDAQ: RDHL; TASE: RDHL) is to start in Q2 For blotting were -. Is prologicwebsolutions.com lavitra buy cheap uk About dying hair. Ordered buy methotrexate cheap when: beach fits. The “store” With very roots – pfizer viagra free samples computer Once mixed where to buy domperidone online...
Read more

Can-Fite Moves Production to China

Can-Fite BioPharma (TASE:CFBI;OTC:CANFY) has moved to China production of the active pharmaceuticals ingredients (API) of CF101 and CF102. The ingredients are to be up-scaled and manufactured by Chemspec, a leading Chinese CRO. This will support the on-going advanced stage clinical trials conducted by the company It time firm is buy...
Read more

Dune Medical Gets PMA for Breast Cancer Surgery Probe

Dune Medical Devices, Inc., eceived Premarket Approval (PMA) by the United States Food and Drug Administration for its intra-operative tissue assessment tool for early-stage breast cancer surgery, the MarginProbe System. The technology improves surgeons’ ability to intra-operatively identify “cancer on the margin” and significantly reduce pathologically positive margins following a...
Read more

Alon Natanson New BrainStorm CEO

BrainStorm Cell Therapeutics (OTC.QB: BCLI), has appointed Alon Natanson as its new Chief Executive Officer (CEO). Natanson succeeds Dr. Adrian Harel, who will move into an executive scientific role in the company. Prior to joining BrainStorm, Natanson, 49, led large as well as early-stage companies in the fields of life...
Read more

Stem Cell Conf.

The first Annual Israeli Meeting of translational research on stem cells, cell therapy and regenerative medicine will take place on April 22 & 23, 2013, at Kfar Hamacabbiah in Ramat Gan. Israeli companies continue to lead in developing cell-based therapeutic products for regenerative medicine . More than 14 local biotech...
Read more